Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.
M Burak Onaran, Anthony B Comeau, Christopher T Seto
Index: J. Org. Chem. 70(26) , 10792-802, (2005)
Full Text: HTML
Abstract
[structure: see text] A series of squaric acid-peptide conjugates were synthesized and evaluated as inhibitors of MMP-1. The cyclobut-3-enedione core was substituted at the 3-position with several functional groups, such as -N(alkyl)OH, -NHOH, and -OH, that are designed to bind to the zinc atom in the active site of the metalloprotease. The 4-position of the cyclobut-3-enedione was derivatized with mono- or dipeptides that are designed to bind in the S1' and S2' subsites of the enzyme, and position the metal chelating group appropriately in the active site for binding to zinc. Positional scanning revealed that -N(Me)OH provided the highest level of inhibition among the chelating groups that were tested, and Leu-Tle-NHMe was the preferred amino acid sequence. A combination of these groups yielded an inhibitor with an IC50 value of 95 microM. For one inhibitor, conversion of one of the carbonyl groups on the cyclobut-3-enedione core to a thiocarbonyl group resulted in a 18-fold increase in potency, and yielded a compound with an IC50 value of 15 microM.
Related Compounds
Related Articles:
2015-12-01
[Toxicol. Appl. Pharmacol. 289 , 177-84, (2015)]
Chiral squaramide derivatives are excellent hydrogen bond donor catalysts.
2008-11-05
[J. Am. Chem. Soc. 130(44) , 14416-7, (2008)]
2015-09-21
[Phys. Chem. Chem. Phys. 17 , 23095-103, (2015)]
2013-01-01
[Anal. Sci. 29(1) , 157-9, (2013)]
2011-03-01
[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 78(3) , 1097-104, (2011)]